PRILIMED 30 DEUS-MEDICAL

£32.00

PRILIMED 30 DEUS-MEDICAL is a dapoxetine-based research compound formulated for laboratory studies investigating selective serotonin reuptake inhibition mechanisms and neurochemical pathways in controlled experimental settings.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
PRILIMED 30 DEUS-MEDICAL
PRILIMED 30 DEUS-MEDICAL
£32.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Understanding PRILIMED 30 DEUS-MEDICAL

PRILIMED 30 DEUS-MEDICAL is a dapoxetine-based selective serotonin reuptake inhibitor (SSRI) formulated exclusively for in-vitro laboratory research applications. This research compound enables scientists to investigate neurochemical modulation pathways and serotonin transport mechanisms in controlled experimental environments. Laboratory researchers at Stroid UK Shop utilise this compound to examine selective neurotransmitter interactions and their effects on cellular receptor binding dynamics.

Experimental Applications in Research

Research applications focus on examining dapoxetine’s selective inhibition properties within serotonin transporter (SERT) studies. Laboratory investigations commonly evaluate this compound’s interaction with 5-HT receptors and its influence on synaptic neurotransmitter concentrations. Scientists studying dapoxetine compounds often examine its rapid onset characteristics and short half-life properties in cellular assays. The compound’s unique pharmacokinetic profile makes it valuable for time-sensitive experimental protocols examining neurotransmitter reuptake mechanisms. Researchers frequently compare dapoxetine’s selectivity profile against other SSRI compounds available through research chemical suppliers to understand differential receptor binding affinities. Advanced studies investigate the compound’s potential interactions with various neurotransmitter systems and its effects on cellular signalling cascades. Laboratory teams examining post-synaptic receptor modulation often incorporate this compound into broader research protocols studying neuroplasticity mechanisms. The compound’s research utility extends to examining its effects on calcium channel activity and intracellular second messenger systems. Scientists investigating related research compounds frequently utilise dapoxetine as a comparative standard in neurotransmitter studies.

Technical Specifications

PRILIMED 30 DEUS-MEDICAL Laboratory Specifications
Active Compound Dapoxetine
Strength 30mg per unit
Chemical Formula Verify with supplier
Molecular Weight Verify with supplier
CAS Number Verify with supplier
Storage Requirements Cool, dry conditions
Shelf Life As specified by manufacturer

Research Compliance Statement

PRILIMED 30 DEUS-MEDICAL is manufactured exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must adhere to institutional safety protocols and regulatory guidelines when handling this compound in laboratory settings.

Related